G variant allele carriers of the CYP1A1 A4889G polymorphism have a higher catalytic enzyme activity 17,18, which results in a higher level of carcinogens in breast tissue and, consequently, a higher level of DNA adducts, which may serve as the initial step in BC development. The gene discussed is CYP1A1; the disease is breast cancer.